Chemical inhibitors of V1RA1 can affect the protein's function through various mechanisms by targeting different components of the neuronal pathways. For instance, Methyllycaconitine acts as a selective antagonist for nicotinic acetylcholine receptors, which are involved in cholinergic signaling. This inhibition can block the acetylcholine receptors that V1RA1 may interact with, hindering its normal sensory functions. Similarly, Bicuculline, by antagonizing GABA(A) receptors, reduces inhibitory neurotransmission, which can indirectly affect V1RA1's role in sensory neurons. Tetrodotoxin offers a more direct approach by binding to and obstructing voltage-gated sodium channels, crucial for action potential initiation and propagation in neurons where V1RA1 operates, thereby inhibiting its function. ω-Conotoxin GVIA specifically targets and inhibits N-type calcium channels, which play a role in neurotransmitter release, potentially affecting V1RA1's function in neuronal communication.
Further, Ibotenic Acid, by acting as an agonist for NMDA glutamate receptors, can lead to excitotoxicity and neuronal damage, subsequently disrupting V1RA1's normal function. Conversely, Kynurenic Acid acts as a broad-spectrum antagonist for excitatory amino acid receptors and can inhibit V1RA1 by blocking glutamatergic neurotransmission. Haloperidol inhibits dopamine receptors, which may alter dopaminergic pathways that V1RA1 is a part of, especially those involved in olfactory processing. Atropine serves to block muscarinic acetylcholine receptors, decreasing activity in neural pathways that V1RA1 might influence. Hexamethonium's role as a nicotinic acetylcholine receptor antagonist can affect V1RA1 by blocking autonomic ganglionic transmission. In a similar vein, Ketamine and Phencyclidine, as NMDA receptor antagonists, inhibit excitatory neurotransmission and alter sensory processing where V1RA1 is involved. Lastly, Amiloride inhibits epithelial sodium channels, which can alter ion homeostasis in sensory neurons expressing V1RA1, thereby affecting their function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methyllycaconitine citrate | 112825-05-5 | sc-253043 sc-253043A | 5 mg 25 mg | $117.00 $398.00 | 2 | |
Known to be a selective antagonist for certain nicotinic acetylcholine receptors (nAChRs), Methyllycaconitine can inhibit V1RA1 by blocking the acetylcholine receptors that V1RA1 may interact with in the sensory neuronal pathways, thus impeding the protein's normal sensory functions. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $80.00 $275.00 | ||
As an antagonist for GABA(A) receptors, Bicuculline inhibits V1RA1 by reducing the inhibitory neurotransmission in the central nervous system, which could indirectly affect the sensory neurons that V1RA1 is associated with, thereby inhibiting its function. | ||||||
Ibotenic acid | 2552-55-8 | sc-200449 sc-200449A | 1 mg 5 mg | $118.00 $412.00 | 1 | |
Ibotenic Acid acts as an agonist for NMDA glutamate receptors, and its excitotoxicity can lead to neuronal damage. This can inhibit V1RA1 by damaging neurons in which V1RA1 is expressed, thus disrupting its normal function. | ||||||
Kynurenic acid | 492-27-3 | sc-202683 sc-202683A sc-202683B | 250 mg 1 g 5 g | $25.00 $56.00 $135.00 | 6 | |
As a broad-spectrum antagonist for excitatory amino acid receptors, Kynurenic Acid can inhibit V1RA1 indirectly by blocking the receptors involved in glutamatergic neurotransmission, which may be crucial for V1RA1's sensory functions. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a dopamine receptor antagonist that affects dopaminergic signaling. By inhibiting dopamine receptors, Haloperidol can indirectly inhibit V1RA1 function by altering the dopaminergic pathways that V1RA1 may be part of, particularly in olfactory processing. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $200.00 | 2 | |
This muscarinic acetylcholine receptor antagonist inhibits parasympathetic nerve impulses. By blocking muscarinic receptors, Atropine can inhibit V1RA1 by decreasing the activity of neural pathways that V1RA1 might influence. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Amiloride serves as an inhibitor of epithelial sodium channels (ENaCs). By inhibiting these channels, it can indirectly inhibit V1RA1 by altering ion homeostasis in the sensory neurons expressing V1RA1, affecting their function. | ||||||